REDCARE PHARMACY INH. news, videos and press releases - Page 3
For more news please use our advanced search feature.
REDCARE PHARMACY INH. - More news...
REDCARE PHARMACY INH. - More news...
- DGAP-News: SHOP APOTHEKE EUROPE: Acquisition of MedApp to Expand in Rx and Medication Management in the Netherlands.
- SHOP APOTHEKE EUROPE: Acquisition of MedApp to Expand in Rx and Medication Management in the Netherlands.
- DGAP-News: SHOP APOTHEKE EUROPE proposes Henriette Peucker for election to its Supervisory Board; Björn Söder to become Chairman of Supervisory Board.
- DGAP-News: SHOP APOTHEKE EUROPE N.V. PUBLISHES AGENDA ANNUAL GENERAL MEETING OF SHAREHOLDERS 2021.
- DGAP-News: SHOP APOTHEKE EUROPE Exceeds Repeatedly Raised Sales and Earnings Guidance for 2020 after Strong Fourth Quarter.
- DGAP-Adhoc: SHOP APOTHEKE EUROPE: Pooling agreement of several shareholders with voting agreement for more than 26% of the voting rights.
- DGAP-News: SHOP APOTHEKE EUROPE announces result of convertible bond placement.
- DGAP-Adhoc: SHOP APOTHEKE EUROPE N.V. increases size of the convertible bond offering due to high demand.
- DGAP-Adhoc: SHOP APOTHEKE EUROPE N.V. launches EUR 200 million convertible bonds.
- DGAP-News: SHOP APOTHEKE EUROPE continues its fast growth: Q4 sales up 38%, full year 2020 growth 38.1%.
- DGAP-News: SHOP APOTHEKE EUROPE: Expansion of Digital Medication Management Capabilities Through Acquisition of SMARTPATIENT.
- DGAP-Adhoc: SHOP APOTHEKE EUROPE Acquires Digital Health Provider SMARTPATIENT.
- DGAP-News: SHOP APOTHEKE EUROPE continues its dynamic growth course and again raises its 2020 guidance.
- DGAP-Adhoc: SHOP APOTHEKE EUROPE N.V. ANNOUNCES REDEMPTION OF ITS EUR 135 MILLION 4.5% CONVERTIBLE BONDS DUE 2023.
- DGAP-Adhoc: SHOP APOTHEKE EUROPE N.V. ENDS DISCUSSIONS AND ANNOUNCES CLEAN-UP OF ITS EUR 135 MILLION 4.5% CONVERTIBLE BONDS DUE 2023.
- DGAP-News: SHOP APOTHEKE EUROPE grows by 39.7% in Q3.
- DGAP-Adhoc: SHOP APOTHEKE EUROPE N.V.:
- DGAP-Adhoc: SHOP APOTHEKE EUROPE N.V. ANNOUNCES TO START DISCUSSIONS OF A POSSIBLE EARLIER CONVERSION OF ITS EUR 135 MILLION 4.5% CONVERTIBLE BONDS DUE 2023.
- DGAP-News: SHOP APOTHEKE EUROPE promoted to MDAX.
- DGAP-News: SHOP APOTHEKE EUROPE: 42% growth and significantly improved bottom line in Q2; adjusted Q2 EBITDA margin 2.7%.
- DGAP-Adhoc: SHOP APOTHEKE EUROPE raises full year 2020 guidance.
- DGAP-News: SHOP APOTHEKE EUROPE: GROWTH ACCELERATES FURTHER TO 42% IN Q2. H1 GROWTH IS 37% NOW.
- DGAP-News: SHOP APOTHEKE EUROPE achieves positive EBITDA ahead of schedule and increases sales by 33% in Q1.
- DGAP-News: SHOP APOTHEKE EUROPE N.V.: Annual General Meeting approves all items on the agenda.
- DGAP-Adhoc: SHOP APOTHEKE EUROPE N.V. successfully completes EUR 65 million capital increase by placing c. 1.12 million new bearer shares with institutional investors on the back of very strong demand.
- DGAP-Adhoc: SHOP APOTHEKE EUROPE N.V. launches an equity offering of new bearer shares by way of an accelerated bookbuild.
- DGAP-News: SHOP APOTHEKE EUROPE: Growth accelerated to 33% in Q1, revenues up to EUR 232 million.
- DGAP-News: SHOP APOTHEKE EUROPE COMMITS TO UN GLOBAL COMPACT STANDARDS.
- DGAP-News: SHOP APOTHEKE EUROPE N.V. PUBLISHES AGENDA ANNUAL GENERAL MEETING OF SHAREHOLDERS 2020
- DGAP-News: SHOP APOTHEKE EUROPE DELIVERED HIGH GROWTH AND BETTER MARGINS IN 2019, ENDING THE YEAR WITH A STRONG Q4.